Different pharmacies use different vial sizes, labels, and even liquid colors (some add B12 or other additives that change appearance)
Key Points: GI symptoms are the most common adverse effects, ranging from expected nausea and vomiting to gastroparesis and, rarely, functional obstruction Delayed gastric emptying has important airway implications and a cautious approach to airway management is warranted Biliary disease is one of the most clinically significant complications, particularly early in treatment and with rapid weight loss Pancreatitis is rare, and current evidence does not support a strong causal relationship EDKA and AKI are uncommon but important to recognize in the right context Conclusions: GLP-1 receptor agonists have transformed the management of diabetes and obesity, with clear benefits in weight loss, glycemic control, and cardiovascular outcomes
GLP-1 drugs slow digestion and suppress appetite, which can cause low energy from reduced nutrient intake or blood sugar fluctuations
Alcohol, on the other hand, disrupts this balance by causing sudden spikes and crashes in blood glucose
There are GLP-1 receptors in blood vessels and on the heart, including, Coviello said, on the sinoatrial nodes that controls the heart rate
Side Effects by System Detailed Management Gastrointestinal (Most Common) Affects 1544% of patients depending on dose and indication